Bevacizumab-induced cardiovascular events: A consequence of cholesterol emboli syndrome?

被引：41
作者：
Mir, Olivier [1 ]
Mouthon, Luc [1 ]
Alexandre, Jerome [1 ]
Mallion, Jean-Michel [1 ]
Deray, Gilbert [1 ]
Guillevin, Loic [1 ]
Goldwasser, Francois [1 ]
机构：
[1] Univ Paris 05, Hop Cochin, Assistance Publ Hop Paris, Unite Oncol Med, F-75679 Paris 14, France
来源：
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2007年 / 99卷 / 01期
关键词：
D O I：
10.1093/jnci/djk011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：85 / 86
页数：2
相关论文
共 7 条
[1]   Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer [J].
Hurwitz, H ;
Fehrenbacher, L ;
Novotny, W ;
Cartwright, T ;
Hainsworth, J ;
Heim, W ;
Berlin, J ;
Baron, A ;
Griffing, S ;
Holmgren, E ;
Ferrara, N ;
Fyfe, G ;
Rogers, B ;
Ross, R ;
Kabbinavar, F .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2335-2342
[2]   Cholesterol crystal embolism: Diagnosis and treatment [J].
Meyrier, A .
KIDNEY INTERNATIONAL, 2006, 69 (08) :1308-1312
[3]   European Society of hypertension recommendations for conventional, ambulatory and home blood pressure measurement [J].
O'Brien, E ;
Asmar, R ;
Beilin, L ;
Imai, Y ;
Mallion, JM ;
Mancia, G ;
Mengden, T ;
Myers, M ;
Padfield, P ;
Palatini, P ;
Parati, G ;
Pickering, T ;
Redon, J ;
Staessen, J ;
Stergiou, G ;
Verdecchia, P .
JOURNAL OF HYPERTENSION, 2003, 21 (05) :821-848
[4]   Phase II trial of bevacizumab in combination with weekly docetaxel in metastatic breast cancer patients [J].
Ramaswamy, Bhuvaneswari ;
Elias, Anthony D. ;
Kelbick, Nicole T. ;
Dodley, Angela ;
Morrow, Mark ;
Hauger, Marsha ;
Allen, Joan ;
Rhoades, Chris ;
Kendra, Kari ;
Chen, Helen X. ;
Eckhardt, S. Gail ;
Shapiro, Charles L. .
CLINICAL CANCER RESEARCH, 2006, 12 (10) :3124-3129
[5]   Angiogenic growth factors and hypertension [J].
Sane D.C. ;
Anton L. ;
Brosnihan K.B. .
Angiogenesis, 2004, 7 (3) :193-201
[6]   Mechanisms of hypertension associated with BAY 43-9006 [J].
Veronese, ML ;
Mosenkis, A ;
Flaherty, KT ;
Gallagher, M ;
Stevenson, JP ;
Townsend, RR ;
O'Dwyer, PJ .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (09) :1363-1369
[7]   A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer [J].
Yang, JC ;
Haworth, L ;
Sherry, RM ;
Hwu, P ;
Schwartzentruber, DJ ;
Topalian, SL ;
Steinberg, SM ;
Chen, HX ;
Rosenberg, SA .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (05) :427-434
1